Purification and Biocompatibility of Fermented Hyaluronic Acid for Its Applications to Biomaterials

  • Choi, Sungchul (School of Life Science and Biotechnology, Korea University) ;
  • Choi, Woncheol (Department of Bioplant, Hanmi Pharm. Co.) ;
  • Kim, Sekweon (Department of Bioplant, Hanmi Pharm. Co.) ;
  • Lee, Su Yeon (Department of Chemical Engineering, Seoul National University of Science and Technology) ;
  • Noh, Insup (Department of Chemical Engineering, Seoul National University of Science and Technology) ;
  • Kim, Chan-Wha (School of Life Science and Biotechnology, Korea University)
  • Received : 2014.01.15
  • Accepted : 2014.03.20
  • Published : 2014.06.01

Abstract

Background: Hyaluronic acid (HA) is of importance due to its diverse applications in pharmaceuticals and medical devices such as dermal filler, adhesion barriers, carrier for cells and bioactive molecules as well as scaffold biomaterials for tissue engineering. Evaluations of purification and biocompatibility of HA are required for its applications to biomaterials. Methods: After synthesizing HA by fermentation of streptococcus zooepidemicus for 25 hr, extensively purification of the fermented broth was performed to remove impurities using a filtration process for insoluble components and cells, and diverse adsorbents for soluble impurities. Its in vitro biocompatibility has been evaluated by measurement of cell counting and assay of cell live and dead. Results: 60% yield of white HA powder was obtained, having 15-17 dL/g intrinsic viscosity with a molecular weight of approximately 1,000 kDa. While low molecular weight impurities and insoluble impurities were successfully removed using a ultrafiltration membrane with 50 KDa molecular weight cut, endotoxins, high molecular weight proteins and nucleic acids were removed from the broth by employing adsorbents such as alumina and activated carbons. Alumina showed the best results for the removal of endotoxins, all of the activated carbons were very effective in the removal of high molecular weight proteins and nucleic acids. The purified HA solution showed excellent cell compatibility with no cell damages as observed by both measurement of cell proliferation and observation of cell viability. Conclusions: We obtained high molecular weight HA with excellent biocompatibility as judged by both measurement of cell proliferation and viability, indicating high possibility of its applications to biomaterials.

Keywords

References

  1. Burdick JA, Prestwich GD: "Hyaluronic acid hydrogels for biomedical applications." Adv Mater, 23(12), 41-56 (2011). https://doi.org/10.1002/adma.201003963
  2. Choh SY, Cross D, Wang C: "Facile synthesis and characterization of disulfide-cross-linked hyaluronic acid hydrogels for protein delivery and cell encapsulation." Biomacromolecules, 12(4), 1126-1136 (2011). https://doi.org/10.1021/bm101451k
  3. Gojgini S, Tokatlian T, Segura T: "Utilizing cell-matrix interactions to modulate gene transfer to stem cells inside hyaluronic acid hydrogels." Mol Pharm, 8(5), 1582-1591 (2011). https://doi.org/10.1021/mp200171d
  4. Burdick JA, Chung C, Jia X, Randolph MA, Langer R: "controlled degradation and mechanical behavior of photopolymerized hyaluronic acid networks." Biomacromolecules, 6(1), 386-391 (2005). https://doi.org/10.1021/bm049508a
  5. Johnson P, Ruffell B: "CD44 and its role in inflammation and inflammatory diseases." Inflamm Allergy Drug Targets, 8(3), 208-220 (2009). https://doi.org/10.2174/187152809788680994
  6. Kang DY, Kim WS, Heo IS, Park YH, Lee S: "Extraction of hyaluronic acid (HA) from rooster comb and characterization using flow field-flow fractionation (FlFFF) coupled with multiangle light scattering (MALS)." J Sep Sci, 33(22), 3530-3536 (2010). https://doi.org/10.1002/jssc.201000478
  7. Meyer K, Palmer J: "The polysaccharide of the vitreous humor." J Biol Chem, 107, 629-634 (1934).
  8. Kendall FE, Heideberger M, Dawson MH: "A serologically inactive polysaccharide elaborated by mucoid strains of group A hemolytic streptococcus." J Biol Chem, 118, 61-69 (1937).
  9. Tawada A, Masa T, Oonuki Y, Watanabe A, Matsuzaki Y, Asari A: "Large-scale preparation, purification, and characterization of hyaluronan oligosaccharides from 4-mers to 52-mers." Glycobioloy, 12(7), 421-426 (2002). https://doi.org/10.1093/glycob/cwf048
  10. Chong BF, Blank LM, Mclaughlin R, Nielsen LK: "Microbial hyaluronic acid production." Appl Microbiol Biotechnol, 66(4), 341-351 (2005). https://doi.org/10.1007/s00253-004-1774-4
  11. Akdamar HA, Sariozlu NY, Ozcan AA, Ersoz A, Denizli A, Say R: "Separtation and purification of hyaluronic acid by glucuronic acid imprinted microbeads." Mater Sci and Eng C, 29(4), 1404-1408 (2009). https://doi.org/10.1016/j.msec.2008.10.038
  12. Volpi N, Maccari F: "Purification and characterization of hyaluronic acid from the mollusk bivalve mytilus galloprovincialis." Biochimie, 85(6), 619-625 (2003). https://doi.org/10.1016/S0300-9084(03)00083-X
  13. Hong SS, Chen J, Zhang JG, Tao YC, Liu LY, "Purification and structure identification of hyaluronic acid." Chin Chem Lett, 15(7), 811-812 (2004).
  14. Rangaswamy V, Jain D: "An efficient process for production and purification of hyaluronic acid from streptococcus equi subsp. zooepidemicus." Biotechnol Lett, 30(3), 493-496 (2008). https://doi.org/10.1007/s10529-007-9562-8
  15. Kablik J, Monheitmd GD, Phd LY, Chang G, Gershkovich J: "Comparative physical properties of hyaluronic acid dermal fillers." Dermatologic surgery, 35(Suppl 1), 302-312 (2009). https://doi.org/10.1111/j.1524-4725.2008.01046.x
  16. Pasquale MD, Gaspare MD: "Effect of hypotonic 0.4% hyaluronic acid drops in dry eye patients: a cross-over study." Cornea, 27(10), 1126-1130 (2008). https://doi.org/10.1097/ICO.0b013e318180e55c
  17. d'Ayala GG, Malinconico M, Laurienzo P: "Marine Derived Polysaccharides for Biomedical Applications: Chemical Modification Approaches." Molecules, 13(9), 2069-2106 (2008). https://doi.org/10.3390/molecules13092069
  18. Hahn SK, Jelacic S, Maier RV, Stayton PS, Hoffman AS: "Antiinflammatory drug delivery from hyaluronic acid hydrogels." J Biomater Sci Polym Ed, 15(9), 1111-1119 (2004). https://doi.org/10.1163/1568562041753115
  19. Awesh KY, Mishra P, Govind PA: "An insight on hyaluronic acid in drug targeting and drug delivery." J Drug Target, 16(2), 91-107 (2008). https://doi.org/10.1080/10611860701794296
  20. Luo Y, Kirker KR, Prestwich GD: "Cross-linked hyaluronic acid hydrogel films: new biomaterials for drug delivery." J Controlled Release, 69(1), 169-184 (2000). https://doi.org/10.1016/S0168-3659(00)00300-X
  21. Leach JB, Bivens KA, Patrick Jr CW, Schmidt CE: "Photocrosslinked hyaluronic acid hydrogels: natural, biodegradable tissue engineering scaffolds." Biotechnol Bioen, 82(5), 578-589 (2003). https://doi.org/10.1002/bit.10605
  22. Kim J, Kim IS, Cho TH, Lee KB, Hwang SJ, Tae G, Noh I, Lee SH, Park Y, Sun K: "Bone regeneration using hyaluronic acid-based hydrogel with bone morphogenic protein -2 and human mesenchymal stem cell." Biomaterials, 28(10), 1830-1837 (2007). https://doi.org/10.1016/j.biomaterials.2006.11.050
  23. Kim J, Park Y, Tae G, Lee KB, Hwang CM, Hwang SJ, Kim IS, Noh I,Sun K: "Characterization of low molecular weight hyaluronic acid based hydrogel and differential stem cell responses in the hydrogel microenvironments." J Biomed Mater Res A, 88A(4), 967-975 (2009). https://doi.org/10.1002/jbm.a.31947
  24. Kim AR, Park HS, Kim SS, Noh I: "biological evaluation of cellulose hydrogel with temperature-responsive particles." Biomater Res, 17(4), 181-186 (2013).